Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy.

The present article describes the first patient with a deficiency of ribose-5-phosphate isomerase (RPI) (Enzyme Commission number 5.3.1.6) who presented with leukoencephalopathy and peripheral neuropathy. Proton magnetic resonance spectroscopy of the brain revealed highly elevated levels of the polyols ribitol and D-arabitol, which were subsequently also found in high concentrations in body fluids. Deficient activity of RPI, one of the pentose-phosphate-pathway (PPP) enzymes, was demonstrated in fibroblasts. RPI gene-sequence analysis revealed a frameshift and a missense mutation. Recently, we described a patient with liver cirrhosis and abnormal polyol levels in body fluids, related to a deficiency of transaldolase, another enzyme in the PPP. RPI is the second known inborn error in the reversible phase of the PPP, confirming that defects in pentose and polyol metabolism constitute a new area of inborn metabolic disorders.

[1]  J. Frahm,et al.  Diffuse White Matter Disease in Three Children: An Encephalopathy with Unique Features on Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy , 1993, Neuropediatrics.

[2]  R. Berger,et al.  Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid prepurification method. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[3]  A. Hart,et al.  Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. , 1999, Radiology.

[4]  Capillary gas chromatography combined with ion trap detection for quantitative profiling of polyols in cerebrospinal fluid and plasma. , 1995, Analytical biochemistry.

[5]  J. Valk,et al.  Leukoencephalopathy associated with a disturbance in the metabolism of polyols , 1999, Annals of neurology.

[6]  G. Sundkvist,et al.  Sorbitol and myo‐inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[7]  L. Wiklund,et al.  Disorders of the cerebral white matter in children. The spectrum of lesions. , 1996, Neuropediatrics.

[8]  R. Schiffmann,et al.  Childhood ataxia with diffuse central nervous system hypomyelination , 1994, Annals of neurology.

[9]  Rune R. Frants,et al.  Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter , 2001, Nature Genetics.

[10]  M. Knaap,et al.  Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. , 2001, American journal of human genetics.

[11]  D. Greene,et al.  Are Disturbances of Sorbitol, Phosphoinositide, and Na+-K+-ATPase Regulation Involved in Pathogenesis of Diabetic Neuropathy? , 1988, Diabetes.

[12]  S. Naidu,et al.  Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter , 2002, Annals of neurology.

[13]  S. Rapoport,et al.  Quantitative analysis of polyols in human plasma and cerebrospinal fluid. , 1989, Journal of chromatography.

[14]  J. Valk,et al.  Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children , 1995, Annals of neurology.

[15]  A. Scherer,et al.  The ribose 5-phosphate isomerase-encoding gene is located immediately downstream from that encoding murine immunoglobulin kappa. , 1995, Gene.

[16]  R. Schutgens,et al.  Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. , 2001, American journal of human genetics.

[17]  M. S. van der Knaap,et al.  Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency. , 2003, Clinical chemistry.

[18]  J. Kinoshita.  Mechanisms initiating cataract formation , 2005 .

[19]  G. Berry.  The role of polyols in the pathophysiology of hypergalactosemia , 2005, European Journal of Pediatrics.

[20]  J. Sredy,et al.  Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy. , 1991, The Journal of diabetic complications.

[21]  F. Barkhof,et al.  A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate , 2003, Annals of neurology.

[22]  F. Gabreëls,et al.  A new leukoencephalopathy with vanishing white matter , 1997, Neurology.

[23]  R. Zimmerman,et al.  In vivo evidence of brain galactitol accumulation in an infant with galactosemia and encephalopathy. , 2001, The Journal of pediatrics.